Progression free survival (PFS) of 74% at 16 months compares favourably to standard of care PFS of 50% at 11.5 months 1 Strong PFS consistent across key subgroups Reaffirms selection of iSCIB1+ and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback